First Light Asset Management’s Vaxcyte PCVX Stock Holding History

First Light Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.1M	Buy	345,157 +203,373	+143%	+$11M	1.22%	25
2026 Q1	$8.24M	Buy	+141,784	New	+$7.7M	0.74%	33
2025 Q2	–	Sell	-94,420	Closed	-$3.57M	–	41
2025 Q1	$3.57M	Buy	+94,420	New	+$7.55M	0.41%	34
2024 Q3	–	Sell	-139,729	Closed	-$10.6M	–	43
2024 Q2	$10.6M	Buy	139,729 +79,445	+132%	+$5.41M	0.92%	34
2024 Q1	$4.12M	Buy	+60,284	New	+$4.17M	0.32%	45

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

First Light Asset Management's PCVX Position: Q2 2026 in Review

First Light Asset Management increased its Vaxcyte (PCVX) stake by 143% in Q2 2026, buying an estimated $11M and bringing the position to 345,157 shares worth $20.1M. The position accounts for 1.22% of the portfolio, ranked #25.

First Light Asset Management first reported a position in PCVX in Q1 2024 and has held it in 5 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

First Light Asset Management held 345,157 shares of Vaxcyte worth $20.1M as of Q2 2026.
First Light Asset Management bought 203,373 Vaxcyte shares in Q2 2026, an estimated $11M.
Vaxcyte made up 1.22% of First Light Asset Management's portfolio in Q2 2026, its #25 holding.
First Light Asset Management first reported a position in Vaxcyte in Q1 2024 and has held it in 5 quarters since.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.